
Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. (CRDL)
WebsitePrice
Market cap
Next catalystExpected 2H 2027CRD-38 — subcutaneous formulation · Study completionSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
History / paused
Financial position
Upcoming milestones
Company funding outlook
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|